BHC
EW icon

Bull Harbor Capital’s Edwards Lifesciences EW Stock Holding History

Bull Harbor Capital’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$310K Sell
3,424
-2,531
-43% -$212K 0.06% 414
2026
Q1 		$477K Buy
+5,955
New +$491K 0.13% 243

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Bull Harbor Capital's EW Position: Q2 2026 in Review

Bull Harbor Capital reduced its Edwards Lifesciences (EW) stake by 43% in Q2 2026, selling an estimated $212K and leaving 3,424 shares worth $310K. The position accounts for 0.06% of the portfolio, ranked #414.

Bull Harbor Capital first reported a position in EW in Q1 2026 and has held it in 2 quarters since. The position peaked at $477K in Q1 2026. 1,330 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Bull Harbor Capital held 3,424 shares of Edwards Lifesciences worth $310K as of Q2 2026.
  • Bull Harbor Capital sold 2,531 Edwards Lifesciences shares in Q2 2026, an estimated $212K.
  • Edwards Lifesciences made up 0.06% of Bull Harbor Capital's portfolio in Q2 2026, its #414 holding.
  • Bull Harbor Capital first reported a position in Edwards Lifesciences in Q1 2026 and has held it in 2 quarters since.
  • Bull Harbor Capital's Edwards Lifesciences position peaked at $477K in Q1 2026.
  • 1,330 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Bull Harbor Capital's 13F filing for Q2 2026, filed 10 Aug 2026.